Exclusive: U.S. cancer drugmaker Ignyta in advanced sale talks - sources
(Reuters) - Ignyta Inc is in advanced talks to sell itself, people familiar with the matter said on Thursday, just three years after the U.S. cancer drugmaker became a public company focused on precision drugs and diagnostics.
from Reuters: Health News http://reut.rs/2BjjOWr
http://bit.ly/2zwRqiM